文献速递前列腺癌

非裔美国男性特异性基因面板预测前列腺癌不良结局

African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.
PubMed 文献 · J Urol · 2019-07-08

研究利用两个多中心队列共1427例男性(发现队列635例,验证队列792例),寻找非裔美国男性中ETS融合阴性前列腺癌的种族特异性预后基因。最终6基因面板(APOD、BCL6、EMP1、MYADM、SRGN、TIMP3)与5年生化复发相关(HR 1.97,95%CI 1.27-3.06,p=0.002),仅在非裔美国男性中提高临床病理变量的预测准确性(60个月时间依赖AUC 0.72)。

要点

  • 6基因面板(APOD、BCL6、EMP1、MYADM、SRGN、TIMP3)与5年生化复发相关,HR 1.97(95%CI 1.27-3.06,p=0.002)。
  • 该面板仅在非裔美国男性中提高预测准确性,60个月时间依赖AUC为0.72。
  • 共鉴定3047个ETS状态依赖差异表达基因,其中362个呈种族特异性差异表达(错误发现率≤0.025)。

核心结论

  • 在非裔美国男性中鉴定出ETS依赖的生物标志物,可预测早期生化复发,且仅在该人群中具有预测价值,作者认为这些标志物是侵袭性疾病生物标志物的理想候选。

研究设计与样本

  • 研究采用两个多中心队列共1427例男性,分别用于发现(635例)和验证(792例)种族特异性预测生物标志物。
  • 使用错误发现率校正的q值鉴定种族和ETS依赖的基因,这些基因在5年内发生生化复发的非裔美国男性中差异表达。
  • 采用主成分建模联合生存分析评估基因面板预测复发的准确性。

主要发现

  • 共鉴定3047个基于ETS状态差异表达的基因,其中362个呈种族特异性差异表达(错误发现率≤0.025)。
  • 81个种族特异性基因在发生生化复发的非裔美国男性中过表达。
  • 最终基因面板包含APOD、BCL6、EMP1、MYADM、SRGN和TIMP3,与5年生化复发相关(HR 1.97,95%CI 1.27-3.06,p=0.002)。
  • 该基因面板仅在非裔美国男性中提高临床病理变量的预测准确性(60个月时间依赖AUC 0.72)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Most prostate cancer in African American men lacks the ETS (E26 transforming specific) family fusion event (ETS-). We aimed to establish clinically relevant biomarkers in African American men by studying ETS dependent gene expression patterns to identified race specific genes predictive of outcomes. MATERIALS AND METHODS: Two multicenter cohorts of a total of 1,427 men were used for the discovery and validation (635 and 792 men, respectively) of race specific predictive biomarkers. We used false discovery rate adjusted q values to identify race and ETS dependent genes which were differentially expressed in African American men who experienced biochemical recurrence within 5 years. Principal component modeling along with survival analysis was done to assess the accuracy of the gene panel in predicting recurrence. RESULTS: We identified 3,047 genes which were differentially expressed based on ETS status. Of these genes 362 were differentially expressed in a race specific manner (false discovery rate 0.025 or less). A total of 81 genes were race specific and over expressed in African American men who experienced biochemical recurrence. The final gene panel included APOD, BCL6, EMP1, MYADM, SRGN and TIMP3. These genes were associated with 5-year biochemical recurrence (HR 1.97, 95% CI 1.27-3.06, p = 0.002) and they improved the predictive accuracy of clinicopathological variables only in African American men (60-month time dependent AUC 0.72). CONCLUSIONS: In an effort to elucidate biological features associated with prostate cancer aggressiveness in African American men we identified ETS dependent biomarkers predicting early onset biochemical recurrence only in African American men. Thus, these ETS dependent biomarkers representing ideal candidates for biomarkers of aggressive disease in this patient population.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Echevarria MI, Awasthi S, Cheng CH, et al. African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome. J Urol. 2019. PMID: 31107158. doi:10.1097/JU.0000000000000193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。